| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $84K | -62.5% | — |
| Cost of Revenue | $1.3M | -0.1% | — |
| Gross Profit | -$1.2M | -13.3% | — |
| R&D Expense | $152K | +147.5% | +4.5% |
| SG&A Expense | $110.7M | +7746.0% | +5822.1% |
| Operating Income | -$102.6M | -3314.2% | -4993.5% |
| Pre-tax Income | -$105.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $10.5M | +26.4% | +325.4% |
| Inventory | $745K | -54.3% | -63.1% |
| Current Assets | $39.7M | +277.9% | +752.1% |
| Total Assets | $444.0M | +2498.5% | +3844.9% |
| Current Liabilities | $10.6M | +339.8% | +131.4% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$11.7M | — | — |
| Capital Expenditures | $3.4M | — | — |
| Investing Cash Flow | -$189.5M | — | — |
| Financing Cash Flow | $210.7M | — | — |
| Free Cash Flow | -$15.1M | — | — |
| -6151.0% |
| Net Income | -$105.3M | -3059.4% | -6151.0% |
| EPS (Basic) | -$4.33 | -220.9% | -240.9% |
| EPS (Diluted) | -$4.33 | -220.9% | -240.9% |
| $10.7M |
| +322.1% |
| +126.3% |
| Stockholders' Equity | $433.2M | +2879.5% | +6559.0% |